Metrorrhagia is a medical term used to describe abnormal vaginal bleeding that occurs between regular menstrual cycles. This type of bleeding is considered to be abnormal because it occurs outside of the regular menstrual cycle, which is usually between 21 to 35 days. It can be caused by a variety of factors, including hormonal imbalance, infection, medications, or even certain medical conditions. Metrorrhagia is typically characterized by a light to medium flow of blood for a period of one to seven days. It may be accompanied by other symptoms, such as severe cramping, abdominal pain, and nausea. In some cases, the bleeding may be accompanied by a foul odor. If the bleeding is severe, it may require medical attention. The cause of metrorrhagia will vary depending on the individual and the underlying medical condition. Common causes include hormone imbalances, such as polycystic ovarian syndrome, or PCOS. Other causes include uterine fibroids, endometriosis, and cervical or uterine infections. Treatment for metrorrhagia depends on the underlying cause. Hormonal imbalances can be treated with oral contraceptives or hormone replacement therapy. Uterine fibroids can be treated with surgery or medications. Endometriosis can be treated with medications or surgery. Cervical or uterine infections can be treated with antibiotics. If the bleeding is severe or persistent, it is important to seek medical attention. Metrorrhagia can be a sign of an underlying medical condition, and it is important to have it evaluated and treated by a healthcare professional.
Title : Evaluate the changes in SP-D levels in plasma during different phases of the menstrual cycle recruited from the Well- Adult Surfactant Protein Study (WASP)
Natnicha Kitti udom, University College London, Thailand
Title : Synergistic antifibrotic potential of protocatechuic acid and D-Carvone in liver protection
Ling Yin, Hefei Comprehensive National Science Center, China
Title : Pathologic findings in women with atypical glandular cells on Pap test
Neda Zarrin-Khameh, Baylor College of Medicine, United States
Title : Non-ablative radiofrequency for pelvic floor dysfunction and female intimate anti-aging: a 6-month prospective multi-centre cohort objectiv
Shaadaiti Wufuer, First Affiliated Hospital of Xinjiang Medical University, China
Title : Benign gynecological conditions and lifetime contraceptive patterns: a population-based analysis of the 2022–2023 national survey of family growth
Mayi Gnofam, Stony Brook University, United States
Title : Hysteroscopic endometrial resection with resectoscope versus Novasure ablation: A look at patient satisfaction with treatment of abnormal uterine bleeding and rates of progression to hysterectomy
Genevieve Kan, West Gippsland Healthcare Group, Australia